Protocol summary

Study aim
Determining the effects of propolis supplementation on sperm parameters, oxidative stress , sperm DNA fragmentation and HOTAIR LncRNA expression in infertile men with asthenozoospermia.
Design
Clinical trial with control group, parallel, double-blind, randomized block method on 60 patients.
Settings and conduct
Patients referring to the infertility clinic of Imam Khomeini Hospital in Ahvaz, after being diagnosed by a specialist doctor, will be included in the study if they have informed consent and meet the inclusion criteria. Patients are randomly divided into two groups receiving propolis and placebo. Participants and evaluators and researchers do not know which group they are in
Participants/Inclusion and exclusion criteria
Inclusion criteria; Willingness to participate in the study At least one year passed since the decision to have children and not using contraceptives Age 20 to 50 years suffering from asthenozoospermia with total sperm motility less than 40% in the semen sample of unknown origin. Exclusion criteria; The presence of a known cause of infertility (hormonal disorders, epididymal duct obstruction and epididymovarcitis), Drug abuse ,Alcohol use Having a chronic disease (diabetes, kidney disease, chronic liver disease), Varicocele, Infectious diseases characterized by fever and leukocytosis. body mass index (BMI) higher than 30 and less than 18.5 kg/m2
Intervention groups
Patients are randomly divided into two groups(propolis or placebo). The propolis group will be given propolis capsules (500 mg 3 times a day) and the placebo group will be given placebo capsules.
Main outcome variables
Semen parameters, oxidative stress , sperm DNA fragmentation and (HOX antisense intergenic RNA) LncRNA ( (HOTAIR)expression

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20231123060155N1
Registration date: 2024-07-06, 1403/04/16
Registration timing: registered_while_recruiting

Last update: 2024-07-06, 1403/04/16
Update count: 0
Registration date
2024-07-06, 1403/04/16
Registrant information
Name
Reza Malihi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 61 3311 5459
Email address
malihi-r@ajums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-06-21, 1403/04/01
Expected recruitment end date
2024-10-22, 1403/08/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effects of Propolis Supplementation on Semen Parameters, Oxidative Stress Biomarkers, Sperm DNA Fragmentation and the Expression of Long Non-Coding RNA HOTAIR in Infertile Men with Asthenozoospermia
Public title
The effect of Propolis supplementation on male infertility
Purpose
Basic scienece
Inclusion/Exclusion criteria
Inclusion criteria:
Willingness to participate in the study At least one year passed since the decision to have children and not using contraceptives Age 20 to 50 years suffering from asthenozoospermia with total sperm motility less than 40% in the semen sample of unknown origin (idiopathic) according to the criteria of the World Health Organization.
Exclusion criteria:
The presence of a known cause of infertility (hormonal disorders, epididymal duct obstruction and epididymovarcitis (inflammation of the testicles and epididymis) Drug abuse Alcohol use Having a chronic disease (diabetes, kidney disease, chronic liver disease) Varicocele Infectious diseases characterized by fever and leukocytosis. body mass index (BMI) higher than 30 and less than 18.5 kg/m2
Age
From 20 years old to 50 years old
Gender
Male
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, the permutation block randomization method will be used. In this two-group clinical trial, the size of the blocks will be considered randomly, 4, 6, and 8 (in this method, the number of people assigned to each group is equal in each of the blocks). The randomization tool is R software, which is used to generate random sequences. For concealment, we use random allocation concealment. This method is used to perform a random sequence on the study participants. In such a way that the assigned group is not known before assigning a person. This method is performed using opaque sealed envelopes with random sequence.
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo and propolis supplement both have the same size capsules with similar colors. The volume and weight filled in both capsules are equal to each other. Propolis and placebo supplements are packaged in identical packages with the coding of drug A and drug B. The person responsible for the packaging of propolis supplements and placebo will determine the type of supplement or placebo without knowing the content by providing the code, which has no role in the implementation and analysis of the study data. In this study, the moderators (including student, supervisors and consultants) as well as patients will be unaware of the type of supplement received by each patient.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Ahvaz Jondishapur University Of Medical Sciences
Street address
Jondishapur University Of Medical Sciences, Golestan Ave. Ahvaz
City
Ahvaz
Province
Khouzestan
Postal code
15794-61357
Approval date
2023-11-18, 1402/08/27
Ethics committee reference number
IR.AJUMS.REC.1402.426

Health conditions studied

1

Description of health condition studied
Asthenozoospermia
ICD-10 code
N045
ICD-10 code description
male infertility

Primary outcomes

1

Description
sperm motility
Timepoint
before the start of the intervention and after 3 months of the intervention
Method of measurement
Spermatogram

Secondary outcomes

1

Description
Oxidative stress
Timepoint
before the start of the intervention and after 3 months of the intervention
Method of measurement
ELISA method

Intervention groups

1

Description
Intervention group: the supplement group will consume three 500 mg capsules containing propolis on the day after each meal for 12 weeks from Shahdineh Golha Co., Isfahan.
Category
Treatment - Other

2

Description
Control group: the placebo group will be given capsules with the same shape, color and container from Shahdineh Golha (500 mg corn starch capsule) 3 times a day after each meal.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Infertility Clinic, Imam Khomeini Hospital (RA), Ahvaz
Full name of responsible person
Majid Karandish
Street address
Jondishapur University Of Medical Sciences, Golestan Ave. Ahvaz
City
Ahvaz
Province
Khouzestan
Postal code
15794-61357
Phone
+98 61 1373 8254
Email
karandish-m@ajums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Dr Mehrnoosh Zakerkish
Street address
Vice of reasearch and technology, Ahvaz Jundi Shapour University of Medical Science, Golestan area, Ahvaz, Khuzestan, Iran
City
Ahvaz
Province
Khouzestan
Postal code
15794-61357
Phone
+98 61 1373 8254
Email
Zakerkish@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Ahvaz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Dr Majid Karandish
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Ahwaz Joundishapoor University of Medical Sciences
City
Ahvaz
Province
Khouzestan
Postal code
15794-61357
Phone
+98 916 618 1688
Email
MKARANDISH@AJUMS.AC.IR

Person responsible for scientific inquiries

Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Dr Majid Karandish
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Ahwaz Joundishapoor University of Medical Sciences
City
Ahvaz
Province
Khouzestan
Postal code
15794-61357
Phone
+98 916 618 1688
Email
MKARANDISH@AJUMS.AC.IR

Person responsible for updating data

Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Dr Majid Karandish
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Ahwaz Joundishapoor University of Medical Sciences
City
Ahvaz
Province
Khouzestan
Postal code
15794-61357
Phone
+98 916 618 1688
Email
MKARANDISH@AJUMS.AC.IR

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...